Delivering up to 270 days of deeply‡ hydrated§ skin with just one treatment2,3,¶,#, SKINVIVE™ is the secret to long-lasting** hydration.2,§
A hydrated1,§ glow2,* that lasts all day, for up to 9 months1,2
SKINVIVE™ targets the five signs of healthy-looking skin,1 noticeably improving clarity,†† smoothness,‡‡ hydration,§ radiance* and tone (colour).1,2,‖ So you can restore your skin’s natural-looking glow2,* and help you meet your individual beauty goals.2,4-6
# A touch up treatment may be required at the clinician’s discretion.1
The SKINVIVE™
difference
After just one SKINVIVE™ treatment,# patients were happy with their skin for up to 9 months.1,§§,‖‖
After 1 month1,§§
9 in 10
were satisfied with their results1, §§
~3 in 4
patients were happy with their skin, even when they first woke up1,***
3x more
patients were happy with how radiant††† their skin looked (than before treatment)1
After 9 months…1,§§
3 in 4
Patients were happy with how healthy† their skin looked1
Nearly
9 in 10
Patients would recommend SKINVIVE™ to a friend1
Discover why real SKINVIVE™ patients love their results1
My skin definitely feels more hydrated, and it looks more hydrated.
ANNA, 38
It’s given me an extra glow.
BETH, 41
My skin feels … firmer, more hydrated and more dewy.
LEE, 37
These quotations are the opinion of individual patients and not scripted by Allergan Aesthetics, an AbbVie company.
Reference:
a. Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791–798.
Footnotes:
¥ Individual results may vary.
Δ Instrument measures of skin hydration, smoothness, and skin deformation parameters were performed on the cheek, forehead, and neck of one side of the face on Day 0 and at 30 days after initial treatment (before touch up), Months 1, 4, 6, and 9 after the last treatment, and Month 1R. Skin hydration was measured using the MoistureMeterD instrument (n=131) and top-up treatment administered at Day 30 (n=31) to correct asymmetry.a
Find your nearest clinic
For a deep,‡ long-lasting** injectable skin hydration§ treatment that helps you meet your individual beauty goals, speak to your aesthetic healthcare practitioner about SKINVIVE™.2,4-6
Footnotes
- *Lasting up to 9 months as reported by 63% of patients (from a subset of 127 patients at 9 months; n=131 initially enrolled) in a composite satisfaction score, including how radiant their facial skin looked.1
- †Lasting up to 9 months as reported by 76.2% of patients (from a subset of 127 patients at 9 months; 1 subject did not respond; n=131 initially enrolled) in a composite satisfaction score, which includes how healthy their facial skin looked.1
- ‡Skin hydration was measured using the MoistureMeterD instrument with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively).2
- §Instrument measures of skin hydration, smoothness, and skin deformation parameters were performed on the cheek, forehead, and neck of one side of the face on Day 0 and at 30 days after initial treatment (before touch up), Months 1, 4, 6, and 9 after the last treatment, and Month 1R. Skin hydration was measured using the MoistureMeterD instrument (n=131) and top-up treatment administered at Day 30 (n=31) to correct asymmetry.2
- ‖Lasting up to 9 months, as reported by 67.7% of patients (from a subset of 127 patients at 9 months; 3 subjects did not respond; n=131 initially enrolled) in a composite satisfaction score, including satisfaction with their skin’s tone (colour).1
- ¶Based on a search of published clinical studies of injectable HA treatments in March 2023. A duration of 9 months of skin hydration was established with SKINVIVE™.3
- #A touch up treatment may be required at the clinician’s discretion.1-3,6
- **Long-lasting is up to 9 months following a single treatment.2
- ††Lasting up to 9 months as reported by 64.6% of patients (from a subset of 127 patients at 9 months; n=131 initially enrolled) in a composite satisfaction score, including how clear their facial skin looked.1
- ‡‡Lasting up to 9 months, as reported by 55.1% of patients (from a subset of 127 patients at 9 months; n=131 initially enrolled) in a composite satisfaction score, including how smooth their facial skin looked.1
- §§Subjects completed the FACE-Q Satisfaction With Skin scale at baseline (Day 0, before treatment), Months 1, 4, 6, and 9 (before repeat treatment, if received), and Month 1 after the repeat treatment (n=131; n=62 received repeat treatment). The Satisfaction With Skin scale is a validated patient-reported outcome instrument designed to assess the impact of treatment from the subject’s perspective. The scale comprises 12 questions about satisfaction with different facial skin attributes (e.g. smoothness, clearness, radiance). Responses are rated on a 4-point scale (1: very dissatisfied, 4: very satisfied). Scores for each item were summed and converted to a scale score (range: 0–100; higher scores indicate greater satisfaction) using the algorithm developed by the FACE-Q developers.1
- ‖‖Defined as having improved satisfaction from baseline on the FACE-Q Satisfaction With Skin scale, as reported by 127 of 131 patients at Month 9.1
- ¶¶Defined as having improved satisfaction from baseline on the FACE-Q Satisfaction With Skin scale, as reported by 131 patients at Month 1.1
- ***At Month 1, 74.0% and 73.3% of 131 patients were somewhat satisfied or very satisfied with their skin at first wake-up and end of day, respectively.1
- †††At Month 1, 82.4% of 131 patients were somewhat satisfied or very satisfied with how radiant their facial skin looked.1
- ‡‡‡Individual results may vary.
References
- Ogilvie P et al. J Cosmet Dermatol. 2020;19(5):1065–1070.
- Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791–798.
- Allergan Aesthetics. Data on File. SKINVIVE by JUVÉDERM® - 9-month duration of skin hydration in clinical trials. REF-108945. September 2023.
- Zarbafian M et al. Dermatol Surg. 2022;48(3):369–372.
- Alexiades M et al. Dermatol Surg. 2023;49(7):682–688.
- SKINVIVE™ by JUVÉDERM® DFU. 20081699. Revision 2023-10-04.
The information on this website is intended for informational and educational purposes only and should not be used as a substitute for advice provided by a qualified aesthetic healthcare professional.
Models received a variety of JUVÉDERM® products, including SKINVIVE™ by JUVÉDERM®. Images provided courtesy of Allergan Aesthetics, an AbbVie company (unless stated otherwise). Actual treatment results may vary. Images are for illustrative purposes only.
Website produced and funded by Allergan Aesthetics, an AbbVie company.
IMPORTANT SAFETY INFORMATION
This content is intended for UK and Irish adult (>18yrs) audiences only. You should always consult a healthcare professional to help you decide if SKINVIVE™ by JUVÉDERM® is right for you and provide you with a full list of potential side effects.
Potential side effects associated with SKINVIVE™ by JUVÉDERM® include temporary injection-site reactions such as redness, swelling, itching, pain, firmness, bumps, bruising, and discolouration. These reactions may occur immediately or may be delayed. As with any injection, there is a risk of infection. This is not a complete list of side effects. If inflammatory reactions persist for more than one week, or if any other side effects develop, seek medical attention as soon as possible.6
Please refer to SKINVIVE by JUVÉDERM® Directions for use (DFU) for a full list of indications, contraindications, precautions for use, and adverse events.
Adverse events should be reported.
Reporting of side effects:
UK patients: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can help by reporting side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at ProductSurveillance_EAME@allergan.com. By reporting side effects, you can help provide more information on the safety of this product.
Irish patients: If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via www.hpra.ie.
